Nasal Congestion
A blocked nose or difficulty breathing comfortably.
Chronic sinusitis can cause nasal congestion, facial pressure, mucus buildup, and a reduced sense of smell.
When swelling blocks the natural sinus drainage pathways, symptoms may continue despite treatment.
Discover how endoscopic sinus surgery, combined with a dissolvable drug-releasing implant, may help manage inflammation during healing.
Explore the EverOpen+ approach and sinus consultation options in Abu Dhabi.
Sinusitis occurs when the lining of the sinuses becomes inflamed. This swelling can interfere with normal mucus drainage, causing congestion, pressure, and other uncomfortable symptoms.
For some people, these symptoms can last for weeks or return after treatment.
A blocked nose or difficulty breathing comfortably.
Discomfort around the cheeks, forehead, or nose.
Episodes of congestion and inflammation that return.
Mucus buildup that may interfere with drainage.
Difficulty detecting smells as usual.
Sinus concerns that continue despite medication or previous surgery.
If nasal blockage, facial pressure, or other sinus symptoms keep returning, an ENT evaluation can help identify the underlying problem and determine suitable treatment options.
A drug-releasing sinus implant is a temporary device designed to deliver anti-inflammatory medication directly to the treated sinus area after surgery.
Instead of remaining permanently, the implant gradually dissolves while the sinus tissues continue healing.
The implant is placed in the treated sinus area as part of the surgical treatment plan.
Anti-inflammatory medication is delivered locally to help manage swelling at the treatment site.
Localized medication helps address inflammation during postoperative recovery.
The implant gradually dissolves in approximately 45–60 days and is not intended to remain permanently.
Swelling can narrow sinus drainage pathways during healing. Managing inflammation after surgery may help maintain the treated passages and reduce the likelihood of blockage returning.
The combination of sinus surgery and localized medication may provide additional inflammation management compared with surgery alone. Individual results can vary.
EverOpen+ is an advanced sinus surgery approach developed by Dr. Muaaz Tarabichi for patients with chronic or recurring sinusitis.
It combines endoscopic sinus surgery with a dissolvable implant that gradually delivers anti-inflammatory medication to the treated sinus area.
The approach focuses on two goals:
By combining these treatment components, EverOpen+ may help reduce the likelihood of sinus blockage returning compared with traditional sinus surgery alone.
Treatment suitability and outcomes depend on individual clinical assessment.
Treatment begins with an ENT assessment to understand your symptoms, previous care, and clinical findings.
An ENT specialist reviews your sinus symptoms, medical history, previous treatment, and examination findings.
Endoscopic surgery may be recommended to improve affected sinus drainage pathways.
The dissolvable implant releases medication into the treated sinus area to help manage postoperative swelling.
The implant gradually dissolves over approximately 45–60 days. Your treating specialist provides appropriate recovery instructions, medication guidance, and follow-up arrangements.
Dr. Muaaz Tarabichi is an ENT specialist with experience in endoscopic surgical techniques, sinus care, and specialist medical education.
He developed the EverOpen+ approach to combine the treatment of affected sinus drainage pathways with localized inflammation management during healing.
His professional activities include involvement with the Tarabichi Stammberger Ear and Sinus Institute (TSESI) and the Sinus Link Network.
Patients considering this approach should undergo an ENT evaluation to determine whether it is appropriate for their condition.
The Sinus Link Network supports professional education and collaboration around advanced sinus care and the EverOpen+ approach.
Explore information about participating specialists, professional activities, and available consultation pathways.
The Sinus Link Network supports professional education and collaboration around advanced sinus care and the EverOpen+ approach.
EverOpen+ is an advanced sinus surgery approach that combines endoscopic treatment of affected sinus drainage pathways with a dissolvable, drug-releasing implant. The implant delivers anti-inflammatory medication locally during healing.
It is a temporary device designed to gradually release anti-inflammatory medication directly to the treated sinus area after surgery, helping manage swelling during recovery.
The implant gradually dissolves in approximately 45–60 days. It is not intended to remain permanently.
In addition to improving affected sinus drainage pathways, EverOpen+ focuses on managing postoperative inflammation through localized anti-inflammatory treatment.
The implant is designed to dissolve naturally within approximately 45–60 days rather than remain permanently. The treating specialist determines appropriate follow-up care.
Recovery varies between patients. Your ENT specialist will provide instructions for medication, postoperative care, and follow-up appointments based on your treatment needs.
You can submit a consultation enquiry through the Resolved Sinus website. The patient coordination team can provide information about available specialist appointments and the next steps.
Get in Touch
Have questions about the EverOpen+ Sinus Surgery? Contact our expert team at TSESI in Abu Dhabi, UAE for personalized consultations and to learn how our innovative technique can help you breathe easier. We are committed to providing the most advanced sinus treatment available.
Call Us
Reach out to our dedicated staff at EverOpen+ Sinus Surgery for immediate assistance. Call us at +971 4 413 1040 or schedule a consultation to discover how our cutting-edge procedures can improve your sinus health.
Visit Us
Conveniently located at NMC Royal Hospital, Khalifa City, Abu Dhabi, EverOpen+ Sinus Surgery provides specialist sinus consultation and treatment in a modern hospital setting. Location: NMC Royal Hospital, Khalifa City, Abu Dhabi, UAE
Discover EverOpen+, an advanced sinus surgery approach developed by Dr. Muaaz Tarabichi to help manage chronic or recurring sinus problems.
EverOpen+ focuses on both endoscopic sinus surgery and postoperative healing, with drug-releasing sinus implants considered when clinically appropriate.
Learn how EverOpen+ works, explore treatment options, and connect with experienced ENT specialists in Abu Dhabi.
EverOpen+ is an advanced sinus surgery approach developed by Dr. Muaaz Tarabichi, intended to help manage chronic or recurring sinus problems by focusing on both the surgical procedure and postoperative healing.
Chronic sinusitis can cause ongoing nasal congestion, facial pressure, reduced sense of smell, and difficulty breathing comfortably through the nose.
For selected patients whose symptoms persist despite appropriate medical treatment, endoscopic sinus surgery may be considered.
EverOpen+ places particular emphasis on postoperative healing and inflammation management. In suitable cases, drug-releasing sinus implants may be used to deliver anti-inflammatory medication locally to the treated tissues.
The aim is to improve sinus drainage, relieve symptoms, and support recovery. Individual outcomes vary, and continued medical management may still be necessary.
EverOpen+ Advanced Sinus Surgery focuses on treating affected sinus pathways while supporting the healing process after surgery.
For selected patients with chronic sinusitis, endoscopic sinus surgery may help improve sinus ventilation and drainage. Postoperative care is important for managing inflammation and supporting recovery.
Drug-releasing sinus implants may be considered when clinically appropriate to deliver anti-inflammatory medication locally during healing.
The treatment plan depends on each patient’s symptoms, medical history, examination findings, and individual clinical needs.
Postoperative healing plays an important role in sinus surgery. During recovery, inflammation, swelling, and scar tissue may affect the treated sinus pathways.
The EverOpen+ approach emphasizes inflammation management and postoperative care alongside endoscopic surgical treatment.
For suitable patients, drug-releasing sinus implants may be used to deliver anti-inflammatory medication locally to the treated tissues. Some bioabsorbable implants also provide temporary structural support during healing.
The implant used with EverOpen+ has been described as being designed to dissolve within approximately 30–45 days. This timeframe must be verified against its specific product documentation before publication.
The goal of treatment is to support healing, improve sinus drainage, and relieve symptoms associated with chronic sinusitis. Outcomes vary, and regular follow-up care remains important.
EverOpen+ may be considered for selected patients experiencing chronic or recurring sinus symptoms that remain troublesome despite appropriate medical treatment.
An ENT specialist may recommend further evaluation for patients experiencing:
Persistent nasal congestion or blockage
Recurring or prolonged sinus symptoms
Facial pressure associated with sinus disease
Reduced sense of smell
Chronic rhinosinusitis with or without nasal polyps
Symptoms that continue despite appropriate medical treatment
Not everyone with these symptoms requires surgery. A specialist assessment is necessary to establish the diagnosis and determine whether endoscopic sinus surgery and associated postoperative treatments may be appropriate.
Dr. Muaaz Tarabichi is an ENT specialist with experience in endoscopic surgery and medical education.
He developed EverOpen+ Advanced Sinus Surgery, an approach focusing on both surgical treatment and postoperative healing.
His work also includes involvement with the Tarabichi Stammberger Ear and Sinus Institute (TSESI) and the Sinus Link Network.
The Sinus Link Network brings together ENT specialists involved in professional education, collaboration, and the EverOpen+ approach to advanced sinus care.
Explore participating specialists, learn about their clinical expertise, and find information about consultation options.
For medical professionals, the network also provides information about educational activities and opportunities for professional participation.
EverOpen+ is an advanced sinus surgery approach developed by Dr. Muaaz Tarabichi, intended to help manage chronic or recurring sinus problems by focusing on both the surgical procedure and postoperative healing.
Some bioabsorbable sinus implants are designed to gradually dissolve after placement. The implant associated with EverOpen+ has been described as having an approximately 30–45-day absorption period. The exact timeframe requires confirmation from the specific device documentation.
EverOpen+ emphasizes postoperative inflammation management alongside endoscopic surgical treatment. Depending on the patient’s clinical needs, drug-releasing sinus implants may also be considered. The actual differences from other available approaches should be discussed with the treating surgeon.
Sinus surgery aims to improve sinus drainage and relieve symptoms associated with chronic sinusitis. It may reduce recurrent sinus problems in suitable patients, but no surgery can guarantee that future infections or symptoms will be completely prevented.
EverOpen+ was developed by Dr. Muaaz Tarabichi, an ENT specialist with experience in endoscopic surgery and medical education. The approach emphasizes surgical treatment and postoperative healing in the management of selected sinus conditions.
Experiencing persistent or recurring sinus symptoms? Learn more about EverOpen+ Advanced Sinus Surgery and available ENT consultation options in Abu Dhabi.
Enquire about EverOpen+, participating ENT specialists and consultation availability.
Contact our team for assistance with consultation enquiries and treatment information.
NMC Royal Hospital, Abu Dhabi, UAE.
Complete the form below and our team can contact you regarding available consultation options.